Literature DB >> 5708696

Metabolic evaluation of the leg blood flow in claudicating patients with arterial obstructions at different levels.

B Pernow, S Zetterquist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5708696     DOI： 10.3109/00365516809076995

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN： 0036-5513            Impact factor:   1.713


× No keyword cloud information.
  15 in total

1.  Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease.

Authors:  Jennifer L Robbins; W Schuyler Jones; Brian D Duscha; Jason D Allen; William E Kraus; Judith G Regensteiner; William R Hiatt; Brian H Annex
Journal:  J Appl Physiol (1985)       Date:  2011-04-21

2.  Abnormal joint powers before and after the onset of claudication symptoms.

Authors:  Panagiotis Koutakis; Jason M Johanning; Gleb R Haynatzki; Sara A Myers; Nicholas Stergiou; G Matthew Longo; Iraklis I Pipinos
Journal:  J Vasc Surg       Date:  2010-08       Impact factor: 4.268

3.  Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease.

Authors:  David C Isbell; Stuart S Berr; Alicia Y Toledano; Frederick H Epstein; Craig H Meyer; Walter J Rogers; Nancy L Harthun; Klaus D Hagspiel; Arthur Weltman; Christopher M Kramer
Journal:  J Am Coll Cardiol       Date:  2006-05-15       Impact factor: 24.094

Review 4.  Nitrite and nitric oxide metabolism in peripheral artery disease.

Authors:  Jason D Allen; Tony Giordano; Christopher G Kevil
Journal:  Nitric Oxide       Date:  2012-03-14       Impact factor: 4.427

5.  Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics: a pilot study.

Authors:  Amy M West; Justin D Anderson; Frederick H Epstein; Craig H Meyer; Klaus D Hagspiel; Stuart S Berr; Nancy L Harthun; Arthur L Weltman; Brian H Annex; Christopher M Kramer
Journal:  Vasc Med       Date:  2012-02       Impact factor: 3.239

6.  Clinical significance of ankle systolic blood pressure following exercise in assessing calf muscle tissue ischemia in peripheral artery disease.

Authors:  Aman Khurana; Julie A Stoner; Thomas L Whitsett; Suman Rathbun; Polly S Montgomery; Andrew W Gardner
Journal:  Angiology       Date:  2012-05-17       Impact factor: 3.619

7.  Abnormal myofiber morphology and limb dysfunction in claudication.

Authors:  Panagiotis Koutakis; Sara A Myers; Kim Cluff; Duy M Ha; Gleb Haynatzki; Rodney D McComb; Koji Uchida; Dimitrios Miserlis; Evlampia Papoutsi; Jason M Johanning; George P Casale; Iraklis I Pipinos
Journal:  J Surg Res       Date:  2015-02-13       Impact factor: 2.192

8.  High-molecular-weight and total adiponectin levels and incident symptomatic peripheral artery disease in women: a prospective investigation.

Authors:  Deborah Y Ho; Nancy R Cook; Kathryn A Britton; Eunjung Kim; Mark A Creager; Paul M Ridker; Aruna D Pradhan
Journal:  Circulation       Date:  2011-10-24       Impact factor: 29.690

9.  Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study.

Authors:  Timothy P Murphy; Donald E Cutlip; Judith G Regensteiner; Emile R Mohler; David J Cohen; Matthew R Reynolds; Joseph M Massaro; Beth A Lewis; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Suzanne Goldberg; Michael R Jaff; Michael W Steffes; Anthony J Comerota; Jonathan Ehrman; Diane Treat-Jacobson; M Eileen Walsh; Tracie Collins; Dalynn T Badenhop; Ulf Bronas; Alan T Hirsch
Journal:  Circulation       Date:  2011-11-16       Impact factor: 29.690

10.  The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods.

Authors:  Timothy P Murphy; Alan T Hirsch; John J Ricotta; Donald E Cutlip; Emile Mohler; Judith G Regensteiner; Anthony J Comerota; David J Cohen
Journal:  J Vasc Surg       Date:  2008-04-25       Impact factor: 4.268
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.